CROX.NASDAQCrocs, INC

Form 4: Crocs Director Thomas Smach Reports Share Sale and Trust Transfers

Sentiment:

SEC Form 4 Filing


Thomas Smach, a director at Crocs, Inc., reported the sale of 10,174 shares and the transfer of 115,513 shares to a family trust in a recent SEC filing.

Summary

  • On May 10, 2024, Thomas Smach, a director of Crocs, Inc., filed a Form 4 with the SEC.
  • The filing reports the sale of 10,174 shares of Crocs common stock at a weighted average price of $140.3162 per share, with prices ranging from $140.0901 to $140.6150.
  • Smach also reported the transfer of 115,513 shares previously held directly to the THOMAS J. SMACH 1996 REV TRUST & LINDA M. SMACH 1996 REV TRUST TEN COM.
  • The filing also indicates beneficial ownership of shares held in trusts for the benefit of Smach's children and shares held in the name of Smach's child and spouse, but Smach disclaims beneficial ownership of these securities.
  • Sara Hoverstock, acting as Attorney-in-Fact, signed the report on May 14, 2024.
  • A Power of Attorney document is included, authorizing Sara Hoverstock, Anne Mehlman, Jessica Leedy, Ned Prusse, Jonathan Schulman and Jason Day to execute SEC filings on Smach's behalf.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for directors and officers of publicly traded companies. It provides transparency to investors regarding the trading activities of company insiders.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
  • The transactions reported are typical for directors managing their personal investments and estate planning.

Stakeholder Impact

  • The share sale could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
  • The trust transfer is unlikely to have a direct impact on stakeholders.

Key Dates

DateDescription
05/10/2024Date of the reported transaction (share sale and trust transfer).
05/10/2024Date of the Power of Attorney execution.
05/14/2024Date the Form 4 was signed by Sara Hoverstock, Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.